HMG-CoA reductase is regulated by salinity at the level of transcription in Haloferax volcanii

被引:29
|
作者
Bidle, Kelly A.
Hanson, Thomas E.
Howell, Koko
Nannen, Jennifer
机构
[1] Rider Univ, Dept Biol, Lawrenceville, NJ 08648 USA
[2] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA
[3] Univ Delaware, Grad Coll Marine Studies, Newark, DE 19711 USA
基金
美国国家科学基金会;
关键词
haloarchaea; HMG-CoA reductase; salt regulation; lipids; carotenoids;
D O I
10.1007/s00792-006-0008-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The moderately halophilic archaeon Haloferax volcanii was surveyed for protein profile changes correlated with growth at high and low salinity. A single polypeptide with an approximate mass of 46 kDa was conspicuously more abundant during growth at high salinity. This protein was identified as HMG-CoA reductase (HMGR), encoded by the hmgR gene. HMGR is a key enzyme in the mevalonate pathway of isoprenoid biosynthesis, the sole route in haloarchaea for lipid and carotenoid production. Enzymatic assays confirmed that HMGR activity is more abundant in cells grown at high salinity. Low salt cultures of H. volcanii contained lower amounts of hmg R transcript compared to cells grown in high salt suggesting that the observed regulation occurs at the level of transcription. Paradoxically, both lipid and carotenold content decreased in H. volcanii grown at high salinity despite the increased levels of HMGR specific activity. To our knowledge, this is the first report demonstrating that the expression of HMGR is regulated in response to non-optimal salinity in a halophilic archaeon.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [31] Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase
    Kim, YS
    Jung, EA
    Shin, JE
    Chang, JC
    Yang, HK
    Kim, NJ
    Cho, KH
    Bae, HS
    Moon, SK
    Kim, DH
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (11) : 1442 - 1445
  • [32] Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease
    Fried, Linda F.
    KIDNEY INTERNATIONAL, 2008, 74 (05) : 571 - 576
  • [33] Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase
    Whitfield, LR
    Stern, RH
    Sedman, AJ
    Abel, R
    Gibson, DM
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2000, 25 (02) : 97 - 101
  • [34] Statin inhibition of HMG-CoA reductase: a 3-dimensional view
    Istvan, E
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (01) : 3 - 8
  • [35] Monitoring the cellular effects of HMG-CoA reductase inhibitors in vitro and ex vivo
    Cicha, I
    Schneiderhan-Marra, N
    Yilmaz, A
    Garlichs, CD
    Goppelt-Struebe, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) : 2046 - 2050
  • [36] Investigation of HMG-CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives
    Ozalp, Lalehan
    Danis, Ozkan
    Yuce-Dursun, Basak
    Demir, Serap
    Gunduz, Cihan
    Ogan, Ayse
    ARCHIV DER PHARMAZIE, 2020, 353 (10)
  • [37] Kinetic characterization of an oxidative, cooperative HMG-CoA reductase from Burkholderia cenocepacia
    Schwarz, Benjamin H.
    Driver, Joseph
    Peacock, Riley B.
    Dembinski, Holly E.
    Corson, Melissa H.
    Gordon, Samuel S.
    Watson, Jeffrey M.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (02): : 457 - 464
  • [38] HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study
    Qu, Kang
    Li, Ming-xi
    Yu, Peng
    Wu, Bai-hua
    Shi, Miao
    Dong, Ming
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] Peptide design of a competitive inhibitor for HMG-CoA reductase based on statin structure
    Pak, Valeriy V.
    Kim, Sung Hee
    Koo, Minseon
    Lee, Nari
    Shakhidoyatov, K. M.
    Kwon, Dae Young
    BIOPOLYMERS, 2006, 84 (06) : 586 - 594
  • [40] Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease
    Rackley, CE
    CLINICAL CARDIOLOGY, 1996, 19 (09) : 683 - 689